Laguna Pharmacueticals' Series A Round

Laguna Pharmacueticals raised a round of funding on November 21, 2011. Investors include Sante Ventures.

Laguna Pharmaceuticals, formerly known as ChanRx, is a biopharmaceutical company advancing vanoxerine for treatment of atrial fibrillation and atrial flutter.…

Articles about Laguna Pharmacueticals' Series A Round: